Physician

Albert P Hirdt

According to 2025 Medicare claims, Albert Hirdt (NPI: 1396792636) practices allergy/immunology in the Kiryas Joel-Poughkeepsie-Newburgh, NY market, with the plurality of this provider's patient population coming from Orange, NY. This provider's primary affiliated billing organization is ALBERT P HIRDT DO PC (NPI: 1811288442; TIN: 061296185) and primary practice location at 12561-1036.

Hirdt's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 92 traditional Medicare patients, billed 1,756 HCPCS/CPT codes, and received $47,848 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 1,532 prescription claims across 145 beneficiaries totaling $1,077,706 in drug costs, led by Icatibant (Icatibant Acetate). DME data shows 29 claims. Open Payments data shows 8 records totaling $256. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has fallen sharply in recent years, from $167,229 to $47,848. Concurrently, Part D prescription costs did not follow a clear longitudinal pattern. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $310 and ending at $336.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	63	8,949	$167,229
2016	71	8,676	$192,346
2017	71	6,317	$146,408
2018	75	5,594	$131,503
2019	92	5,266	$134,842
2020	90	4,972	$143,766
2021	81	3,950	$116,790
2022	N/R	N/R	N/R
2023	84	1,967	$63,982
2024	92	1,756	$47,848

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	50	307	$952,227
2016	54	357	$1,722,022
2017	54	405	$2,425,724
2018	67	539	$2,149,394
2019	94	664	$1,756,757
2020	105	867	$1,327,925
2021	124	1,089	$1,524,796
2022	143	1,234	$1,473,418
2023	152	1,521	$901,316
2024	145	1,532	$1,077,706

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	24	$2,875
2017	N/R	39	$28,481
2018	N/R	64	$42,352
2019	N/R	50	$46,072
2020	N/R	68	$2,741
2021	N/R	64	$2,221
2022	N/R	37	$1,187
2023	N/R	37	$1,116
2024	N/R	29	$934

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	71	132	$88
95165	Professional service for preparation and provision of 1 or more antigens	15	340	$11
95117	Professional service for multiple injections of allergen	15	210	$10

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Icatibant	Icatibant Acetate	11	53	$231,504
Dupixent Syringe	Dupilumab	31	868	$128,079
Xolair	Omalizumab	36	1,456	$110,770
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	38	1,800	$36,130
Cromolyn Sodium	Cromolyn Sodium	66	1,560	$18,482

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7626	Budesonide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 0.5 mg	N	N/R	14	$598
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	15	$336

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	8	$256	Blueprint Medicines Corporation
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albert P. Hirdt?

Tedicare shows public-source Medicare data for Albert P. Hirdt (NPI 1396792636), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albert P. Hirdt have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Albert P. Hirdt?

Albert P. Hirdt is linked to ALBERT P HIRDT DO PC (billing NPI 1811288442) in the available physician profile data.

Does Albert P. Hirdt have Open Payments data?

Albert P. Hirdt has 8 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.